Joint ventures/collaborations | Science and Enterprise

Study Underway of Depression, Bipolar Disorder Genetics

By Alan, on August 2nd, 2017%

A large-scale study by two companies and a think tank started enrolling participants to learn more about the role of genetics in major depressive and bipolar disorders. . . . → Read More: Study Underway of Depression, Bipolar Disorder Genetics

University, Company Employ AI for Anti-Aging Drugs

By Alan, on August 2nd, 2017%

The medical analytics company Insilico Medicine is partnering with a university in Denmark to apply artificial intelligence to find new treatments for diseases associated with early aging. . . . → Read More: University, Company Employ AI for Anti-Aging Drugs

Exosuit Shown to Improve Walking for Stroke Patients

By Alan, on July 27th, 2017%

A robotic device built and worn like clothing helps improve lower-limb walking performance for a group of people partially paralyzed with stroke. . . . → Read More: Exosuit Shown to Improve Walking for Stroke Patients

Takeda, Biosurfaces Partner on Nanofiber Devices

By Alan, on July 25th, 2017%

Takeda Pharmaceutical Company is joining with a developer of medical devices from nanoscale bioactive fibers to design new devices for gastrointestinal, or GI, disorders. . . . → Read More: Takeda, Biosurfaces Partner on Nanofiber Devices

Lilly Licensing Autoimmune Therapy in $400M Deal

By Alan, on July 24th, 2017%

Drug maker Eli Lilly and Company is licensing a therapy from a biotechnology company that produces self-correcting cells for people with disorders caused by a malfunctioning immune system. . . . → Read More: Lilly Licensing Autoimmune Therapy in $400M Deal

Drug maker GlaxoSmithKline is hiring a company that applies artificial intelligence for drug discovery and design to identify new small-molecule compounds for up to 10 disease targets. . . . → Read More: Glaxo Using Artificial Intelligence for Drug Discovery

Start-Up to Offer Neuro Disorder Speech Analytics App

By Alan, on June 27th, 2017%

A start-up enterprise in Germany is commercializing a software app to detect early signs of cognitive decline, found in dementia and other neurodegenerative disorders. . . . → Read More: Start-Up to Offer Neuro Disorder Speech Analytics App

Science & Enterprise subscription

Guest Posts

Please share Science & Enterprise

Specials

Affiliations

Study Underway of Depression, Bipolar Disorder Genetics

University, Company Employ AI for Anti-Aging Drugs

Exosuit Shown to Improve Walking for Stroke Patients

Takeda, Biosurfaces Partner on Nanofiber Devices

Lilly Licensing Autoimmune Therapy in $400M Deal

Arizona Medical Marijuana Operators Merge to Create Super Dispensary

Grant Funding Automated Genome Editing System

Start-Up Applying Artificial Intelligence to New Drug Uses

Glaxo Using Artificial Intelligence for Drug Discovery

Start-Up to Offer Neuro Disorder Speech Analytics App

Welcome to Science & Enterprise

Here’s what’s new …

Follow us on Facebook

Alan Kotok’s articles on

Search by tag